Keros Therapeutics Inc KROS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
60.57UNCH (UNCH)
Volume
9,595
Close
60.57quote price arrow up+3.47 (+6.08%)
Volume
562,399
52 week range
27.02 - 73.00
Loading...
  • Open57.32
  • Day High62.19
  • Day Low57.32
  • Prev Close57.10
  • 52 Week High73.00
  • 52 Week High Date02/29/24
  • 52 Week Low27.02
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap2.185B
  • Shares Out36.07M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change52.34

KEY STATS

  • Open57.32
  • Day High62.19
  • Day Low57.32
  • Prev Close57.10
  • 52 Week High73.00
  • 52 Week High Date02/29/24
  • 52 Week Low27.02
  • 52 Week Low Date10/26/23
  • Market Cap2.185B
  • Shares Out36.07M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change52.34

RATIOS/PROFITABILITY

  • EPS (TTM)-5.19
  • P/E (TTM)-11.66
  • Fwd P/E (NTM)-11.39
  • EBITDA (TTM)-169.126M
  • ROE (TTM)-50.19%
  • Revenue (TTM)150,999.993
  • Gross Margin (TTM)-
  • Net Margin (TTM)-101,319.20%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Keros Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel therapeutics to treat a range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-B), family of proteins. Its lead product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic...
Ran Nussbaum
Independent Chairman of the Board
Jasbir Seehra Ph.D.
Chief Executive Officer, Director
Christopher Rovaldi
Chief Operating Officer
Keith Regnante
Chief Financial Officer
Address
1050 Waltham Street, Suite 302
Lexington, MA
02421
United States

Top Peers

SYMBOLLASTCHG%CHG
CLDX
Celldex Therapeutics Inc
42.56+1.70+4.16%
DYN
Dyne Therapeutics Inc
26.08+0.08+0.31%
RCKT
Rocket Pharmaceuticals Inc
23.47+0.70+3.07%
GERN
Geron Corp
3.93-0.02-0.51%
KURA
Kura Oncology Inc
20.63+0.04+0.19%